# Zahir Amoura

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/zahir-amoura/

## Facts

| Field | Value |
| --- | --- |
| Citations | 42,655 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 108 |
| i10-index | 402 |
| Last Known Institution | Centre National de la Recherche Scientifique |
| OpenAlex ID | https://openalex.org/A5034623450 |
| ORCID iD | https://orcid.org/0000-0003-0292-9043 |
| Works | 1,052 |

## Researcher papers

- [Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis](https://scholariq.org/papers/two-year-randomized-controlled-trial-of-belimumab-in-lupus-nephritis/)
- [High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses](https://scholariq.org/papers/high-prevalence-of-braf-v600e-mutations-in-erdheim-chester-disease-but-not-in/)
- [Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study](https://scholariq.org/papers/clinical-features-and-prognostic-factors-of-listeriosis-the-monalisa-national/)
- [Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort](https://scholariq.org/papers/paediatric-multisystem-inflammatory-syndrome-temporally-associated-with-sars-cov/)
- [The 2023 <scp>ACR</scp>/<scp>EULAR</scp> Antiphospholipid Syndrome Classification Criteria](https://scholariq.org/papers/the-2023-scp-acr-scp-scp-eular-scp-antiphospholipid-syndrome-classification/)
- [COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study](https://scholariq.org/papers/covid-19-outcomes-in-patients-with-inflammatory-rheumatic-and-musculoskeletal/)
- [Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine](https://scholariq.org/papers/clinical-course-of-coronavirus-disease-2019-covid-19-in-a-series-of-17-patients/)
- [Renal toxicities associated with pembrolizumab](https://scholariq.org/papers/renal-toxicities-associated-with-pembrolizumab/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Histiocytic Disorders and Treatments](https://scholariq.org/topics/histiocytic-disorders-and-treatments/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions-2/)
- [Sarcoidosis and Beryllium Toxicity Research](https://scholariq.org/topics/sarcoidosis-and-beryllium-toxicity-research/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)

## Researcher university

- [Centre National de la Recherche Scientifique](https://scholariq.org/institutions/centre-national-de-la-recherche-scientifique/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.